Orthofix Medical Inc. Payments to Acquire Productive Assets
Orthofix Medical Inc. (OFIX) reported Payments to Acquire Productive Assets of $23.31 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-05
- Orthofix Medical Inc. payments to acquire productive assets for the quarter ending 2026-06-30 was $12.65M, a 77.90% increase year-over-year.
- Orthofix Medical Inc. payments to acquire productive assets for the quarter ending 2026-03-31 was $10.66M, a 58.27% increase year-over-year.
- Orthofix Medical Inc. payments to acquire productive assets for the quarter ending 2025-12-31 was $10.88M, a 27.50% increase year-over-year.
- Orthofix Medical Inc. payments to acquire productive assets for the quarter ending 2025-09-30 was $9.90M, a 70.41% increase year-over-year.
- Orthofix Medical Inc. payments to acquire productive assets for fiscal 2025 was $34.63M, a 0.72% decline from fiscal 2024.
- Orthofix Medical Inc. payments to acquire productive assets for fiscal 2024 was $34.88M, a 43.79% decline from fiscal 2023.
- Orthofix Medical Inc. payments to acquire productive assets for fiscal 2023 was $62.05M, a 167.92% increase from fiscal 2022.
- Orthofix Medical Inc. payments to acquire productive assets for fiscal 2022 was $23.16M.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $23.31M 10-Q · filed 2026-08-05 | $34.19M derived: sum of 3 quarters · filed 2026-08-05 | $44.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $10.66M 10-Q · filed 2026-05-05 | $21.54M derived: sum of 2 quarters · filed 2026-05-05 | $31.44M derived: sum of 3 quarters · filed 2026-05-05 | $38.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $10.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $20.78M derived: sum of 2 quarters · filed 2026-02-24 | $27.89M derived: sum of 3 quarters · filed 2026-08-05 | $34.63M 10-K · filed 2026-02-24 |
| 2025-09-30 | $9.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $17.01M derived: sum of 2 quarters · filed 2026-08-05 | $23.75M 10-Q · filed 2025-11-04 | $32.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $13.85M 10-Q · filed 2026-08-05 | $22.38M derived: sum of 3 quarters · filed 2026-08-05 | $28.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $6.74M 10-Q · filed 2026-05-05 | $15.27M derived: sum of 2 quarters · filed 2026-05-05 | $21.08M derived: sum of 3 quarters · filed 2026-05-05 | $30.80M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $8.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $14.34M derived: sum of 2 quarters · filed 2026-02-24 | $24.06M derived: sum of 3 quarters · filed 2026-02-24 | $34.88M 10-K · filed 2026-02-24 |
| 2024-09-30 | $5.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $15.53M derived: sum of 2 quarters · filed 2025-11-04 | $26.34M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $9.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $20.53M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $10.82M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $62.05M 10-K · filed 2026-02-24 | |||
| 2022-12-31 | $23.16M 10-K · filed 2025-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |